June 5th

LabCorp(R) and Vanda Pharmaceuticals Collaborate to Offer Genetic Tests

Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH), one of the world’s leading clinical trials and genetic testing laboratories, and Vanda Pharmaceuticals Inc. (Nasdaq: VNDA), a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders, today announced an exclusive alliance to develop and commercialize a series of diagnostic tests for genetic markers identified by Vanda in the course of its clinical development of Fanapta™ (iloperidone), a novel atypical antipsychotic drug candidate under FDA review for the treatment of schizophrenia. Financial terms of the agreement were not disclosed. Read more: Vanda Pharmaceuticals Inc ( VNDA )

June 5th

Applied Energetics Receives Contract for Marine Corps Systems

Applied Energetics, Inc., (Nasdaq: AERG) today announced it has received a cost-plus contract for a classified system for the U.S. Marine Corps. Due to the sensitivity of the effort the customer has asked that program details not be publicly disclosed.

Regarding the contract, Dana Marshall, Chairman, CEO and President of Applied Energetics commented: “We appreciate the efforts of our customers, the U.S. Marine Corps, in moving this program forward at an accelerated pace, and look forward to continuing our promising collaboration with them.”

The agreement is a Cost Plus Fixed Fee (CPFF) contract issued by the U.S. Army (Aberdeen Proving Ground, MD) with a ceiling value of approximately $9.3 million. The contract period of performance is twelve months. Read more: Applied Energetics Inc ( AERG )

June 5th

Ipsen to Acquire Tercica

-Tercica, Inc. (Nasdaq: TRCA) today announced that Tercica and Ipsen, S.A. (Euronext: IPN) have entered into a definitive merger agreement by which an affiliate of Ipsen would acquire all of the shares of Tercica common stock that Ipsen does not currently own at a price of $9.00 per share in cash, which values Tercica at approximately $663 million. This transaction, which is subject to approval by Tercica stockholders holding a majority of the outstanding Tercica common stock, has been unanimously approved by Tercica’s Board of Directors following recommendation and approval by a Special Committee of Tercica’s Board of Directors comprised of three independent non-employee directors. Read more: Tercica Inc ( TRCA )

The first mobile ticketing solution using UK mobile payment initiative payforIT has been launched today by interactive mobile specialists Dialogue Communications and AEI Mobile. Mobile ticketing will enable party-goers to purchase tickets to a London nightclub via their mobile phone using payforIT, and to receive the tickets via SMS.

PayforIT is the cross-operator payment initiative that allows consumers to purchase goods and services via their mobile phone up to the value of £10. Dialogue and AEI Mobile will be working together to provide a mobile ticketing solution for Drum & Bass Arena event taking place at Scala Club in London on 15th August and tickets are on sale today for £10.

Dialogue was the first company to take payforIT live in January 2007, when it was used predominantly by mobile content providers to sell content via the mobile internet. Read more: Dialogue And AEI Launch UK’s First Mobile Ticketing Solution Using PayforIT